Exhibit 107.1
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Neumora Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||||
| Newly Registered Securities | ||||||||||||||||
| Fees to Be Paid |
— | — | — | — | — | — | — | — | ||||||||
| Equity | Common Stock, par value $0.0001 per share | (1)(2) | (1) | (3) | ||||||||||||
| Equity | Preferred Stock, par value $0.0001 per share | (1)(2) | (1) | (3) | ||||||||||||
| Debt | Debt Securities | (1) | (1) | (3) | ||||||||||||
| Other | Warrants | (1) | (1) | (3) | ||||||||||||
| Other | Units | (1) | (1) | (3) | ||||||||||||
| Unallocated (Universal) Shelf | Rule 457(o) |
(1) | (1) | $600,000,000(3) | $153.1 per $1,000,000 |
$91,860(4) | ||||||||||
| Fees Previously Paid |
Equity | Common Stock, par value $0.001 per share | Rule 457(o) | — | — | $285,554,049.58 | $153.1 per $1,000,000 |
$43,718.32(5) | ||||||||
| Total Offering Amounts | $600,000,000 | $91,860 | ||||||||||||||
| Total Fees Previously Paid | $43,718.32 | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $48,141.68 | |||||||||||||||
| (1) | An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of Common Stock is being registered as may be issued from time to time upon conversion of any Debt Securities that are convertible into Common Stock or pursuant to any anti-dilution adjustments with respect to any such convertible Debt Securities. | |
| (2) | Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights plan then in effect, if applicable under the terms of any such plan. | |
| (3) | Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities, depositary shares or preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $400,000,000. | |
| (4) | Calculated pursuant to Rule 457(o) under the Securities Act. | |
| (5) | This amount includes the registration fee of $43,718.32 previously paid in connection with the offering, issuance and sale of up to $300,000,000 of the registrant’s common stock pursuant to this registration statement and a sales agreement, dated as of October 1, 2024, by and between the registrant and Leerink Partners LLC. The $600,000,000 of shares of common stock registered pursuant to this registration statement includes $285,554,049.58 of shares of common stock, or the Unsold Shares, registered pursuant to Registration Statement No. 333-282460 filed on October 1, 2024. |